MEDSTRxADE HEALTH, INC

Nasdaq trxadehealth.com


$ 6.69 $ -0.26 (-3.68 %)    

Wednesday, 11-Sep-2024 11:34:46 EDT
QQQ $ 474.48 $ 1.05 (0.22 %)
DIA $ 414.78 $ 2.15 (0.52 %)
SPY $ 561.51 $ 1.24 (0.22 %)
TLT $ 100.48 $ 0.00 (0 %)
GLD $ 238.46 $ 0.88 (0.37 %)
$ 6.8
-- x --
-- x --
-- - --
$ 2.30 - $ 27.76
13,725
na
9.92M
$ 0.85
$ 2.35
TBD
na
na ($ 1.40)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 06-26-2024 03-31-2024 10-Q
3 04-22-2024 12-31-2023 10-K
4 01-16-2024 09-30-2023 10-Q
5 08-18-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-27-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 07-25-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-28-2022 12-31-2021 10-K
12 10-25-2021 09-30-2021 10-Q
13 07-26-2021 06-30-2021 10-Q
14 04-26-2021 03-31-2021 10-Q
15 03-29-2021 12-31-2020 10-K
16 10-26-2020 09-30-2020 10-Q
17 07-27-2020 06-30-2020 10-Q
18 05-04-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 10-28-2019 09-30-2019 10-Q
21 07-26-2019 06-30-2019 10-Q
22 05-13-2019 03-31-2019 10-Q
23 03-22-2019 12-31-2018 10-K
24 10-26-2018 09-30-2018 10-Q
25 07-27-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 03-02-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-04-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-30-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-05-2016 06-30-2016 10-Q
34 04-20-2016 03-31-2016 10-Q
35 03-28-2016 12-31-2015 10-K
36 11-02-2015 09-30-2015 10-Q
37 07-30-2015 06-30-2015 10-Q
38 05-04-2015 03-31-2015 10-Q
39 03-23-2015 12-31-2014 10-K
40 10-30-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Market-Moving News for June 27th
06/27/2024 12:37:40

CASI: 92% | CASI Pharmaceuticals Announced Plan To Submit CID-103 IND Application; Also Announces Receipt Of A Non-binding Prop...

 trxade-health-q1-eps-640-down-from-045-yoy

Trxade Health (NASDAQ:MEDS) reported quarterly losses of $(6.40) per share. This is a 1322.22 percent decrease over losses of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION